Clinical trials of an mRNA vaccine have begun, and researchers expect broadly positive outcomes in the fight against the widespread illness.
Influenza vaccines are recommended annually, but there’s now an increasing number of different vaccine types. Here’s what to know about this year’s shots.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
Hospitals are struggling, with ambulances ramping outside emergency departments, and patients facing long waits for care. But doing more of the same won’t fix the problem.
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
A new collection project aims to crack the COVID-19 immunity code, and predict who will be hardest-hit.
Our post-coronavirus pandemic future will be very different to the one we anticipated, as it reshapes relationships, governments, business, and broader society.
Rather than basing decisions about ICU access on age, clinicians need to consider the potential benefits and burdens of treatments proposed for every patient.
How prepared are we to give up some personal freedoms, and how do we allocate scarce resources? These are just some of the tough questions we face.
The adjuvanted flu vaccine is free for over-65s and offers better protection than the standard vaccine. Here's what the research says.
Two free flu vaccines will improve protection for older people, but like those already available, they're not perfect.
After a horrific 2017 flu season, there's more interest than ever in developing a better, more universal vaccine. T-cells might hold the answer.
Dummy text
